Cano Health

Cano Health, Inc. operates primary care centers and supports affiliated medical practices that engages in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico. It provides population health management tools including telehealth, prescription home delivery, wellness programs, transition of care, and high-risk and complex care management. The company was founded by Marlow Hernandez in 2009 and is headquartered in Miami, FL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Cano Health reports strong 2022 performance, eyes growth opportunities

Cano Health demonstrated strong performance in membership growth and revenue generation in 2022, despite facing challenges in revenue per member and goodwill impairment. Strategic actions to enhance liquidity and operational efficiency position the company for future growth.
The company's focus on optimizing operations, expanding strategically, and improving cash flows presents opportunities for sustainable growth and profitability. Renegotiated contracts and cost-saving initiatives aim to address challenges and drive financial performance.
With a clear roadmap for 2023, including membership and revenue targets, Cano Health is poised to capitalize on its strengths, navigate challenges, and leverage opportunities to drive value for stakeholders. The company's financial health and growth prospects remain promising.

Cano Health reports robust Q1 performance, focuses on profitability

Cano Health's Q1 2023 performance showcased strong revenue growth, membership expansion, and a focus on operational efficiency and profitability.
The company faces challenges in managing increased MCR and seasonality impacts but is strategically positioned to capitalize on opportunities for growth and cost optimization.
By divesting non-core assets, reallocating resources, and focusing on Medicare Advantage business, Cano Health aims to drive profitability and enhance shareholder value.
Overall, Cano Health's performance, strategic initiatives, and financial position indicate a positive outlook for continued growth and operational improvements.

Cano Health reports revenue growth but faces financial challenges in Q2 2023

Cano Health's Q2 2023 showcased revenue growth and membership expansion, but challenges with financial performance and liquidity require strategic focus.
The company's strengths in core markets and operational efficiency initiatives offer opportunities for growth and improved profitability.
Navigating challenges with Medicare Risk Adjustment, unexpected expenses, and market exits will be crucial for Cano Health's future success and financial stability.

Cano Health reports Q3 losses, focuses on cost management strategies

Cano Health's Q3 2023 performance reflects a mix of challenges and strengths, with a focus on cost management and operational efficiency.
The company's strategic initiatives in the Medicare Advantage business show promise for revenue growth and cost reductions.
While facing liquidity concerns and financial losses, Cano Health is actively addressing these challenges through restructuring and cost-saving measures.
Opportunities for growth and improved financial performance exist through further cost optimization and strategic decision-making.

Cano Petroleum, Inc. operates as an independent oil and natural gas company. The company was founded by Jeffery S. Johnson in 1997 and is headquartered in Tulsa, OK.

Humana

Humana Inc.  HUM, +0.67% and other possible buyers are circling Cano Health Inc. CANO, +32.17% ,  according to people familiar with the situation, as healthcare heavyweights scramble to snap up primary-care providers.

Humana among potential buyers for Cano Health

CVS Health

Humana and CVS Health are among the several companies looking to buy senior-care facility operator Cano Health , according to media reports on Thursday, sending Cano's shares up about 50%.

Humana, CVS among firms looking to buy Cano Health - reports

Humana Inc. and other possible buyers are circling Cano Health Inc., according to people familiar with the situation, as healthcare heavyweights scramble to snap up primary-care providers.

Humana, Other Potential Buyers Circle Cano Health

MIAMI , Sept. 12, 2022 /PRNewswire/ -- Cano Health Inc. ("Cano" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced it will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022.

Cano Health to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

MIAMI , Sept. 6, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO) today announced that it has filed two registration statements on Form S-3 (the "S-3 Registration Statements") with the United States Securities and Exchange Commission ("SEC") that replace prior registration statements on Form S-1.

Cano Health Files Form S-3 Registration Statements to Replace Prior S-1 Registration Statements; No Issuance or Sale by Cano Health

Investors appear to be anticipating a potential sale of the company.

Why Cano Health Stock Is Skyrocketing This Week

Urges Company to Actively Pursue Strategic Alternatives and Sale of the Company NEW YORK , Aug. 22, 2022 /PRNewswire/ -- Owl Creek Asset Management, L.P. ("Owl Creek"), on behalf of its affiliated investment funds, today sent a letter to the Cano Health, Inc. ("Cano or the "Company") (NYSE: CANO) Board of Directors strongly encouraging the Company to pursue strategic alternatives by engaging with investment bankers and other advisors to pursue a sale to a strategic buyer.

Owl Creek Asset Management Delivers Letter to Cano Health Board of Directors

Signify Health

Oak Street Health

Shares of Cano Health Inc. CANO, +14.83% , which provides primary care to seniors, soared 17.6% in trading on Monday, while shares of Oak Street Health Inc. OSH, +4.59% , another medical provider for people covered by Medicare, jumped 3.5%. Amazon Inc. AMZN, -3.26% , CVS Health Corp. CVS, -1.51% , and UnitedHealth Group UNH, -0.31% are reportedly in a bidding war to buy Signify Health Inc. SGFY, +36.84% , a home-health provider, according to a report in The Wall Street Journal.

Cano Health, Oak Street stocks rally following WSJ report about Amazon's reported interest in buying Signify Health

Cano Health, Inc. (NYSE:CANO ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Marlow Hernandez - Chairman and Chief Executive Officer Brian Koppy - Chief Financial Officer Conference Call Participants Gary Taylor - Cowen A.J. Rice - Credit Suisse Adam Ron - Bank of America Andrew Mok - UBS Josh Raskin - Nephron Research Jason Cassorla - Citigroup Parker Snure - Raymond James Justin Lake - Wolfe Research Operator Good afternoon, and welcome to Cano Health's Second Quarter 2022 Earnings Call.

Cano Health, Inc. (CANO) CEO Marlow Hernandez on Q2 2022 Results - Earnings Call Transcript

MIAMI , Aug. 9, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the second quarter ended June 30, 2022. Second Quarter Financial Results Total membership of 281,525, including 163,947 Medicare capitated members, an increase of 80% and 47%, respectively year-over-year Total revenue of $689.4 million, an increase of 101% year-over-year Net loss of ($14.6) million, benefiting from a $30.2 million fair value adjustment of warrant liabilities Adjusted EBITDA 1  of $29.4 million, compared to ($15.2) million in the second quarter of 2021; results in the quarter were impacted by $6 million of unfavorable prior year development (PYD) related to Medicare Direct Contracting Entity (DCE) program described below Accelerated membership growth in the second quarter resulted in a larger proportion of new, higher acuity Medicare Advantage and Medicaid members, contributing to a medical cost ratio2, or MCR, of 82.6%.

Cano Health Announces Financial Results for the Second Quarter 2022

Appoints Bob Camerlinck Chief Operating Officer and Amy Charley Chief Administrative Officer.Enhanced leadership team will drive strategic initiatives to maximize Cano Health's strengths and position the company for the next stage of growth. Appoints Bob Camerlinck Chief Operating Officer and Amy Charley Chief Administrative Officer.Enhanced leadership team will drive strategic initiatives to maximize Cano Health's strengths and position the company for the next stage of growth.

Cano Health Expands Executive Leadership Team

MIAMI, FL, July 26, 2022 (GLOBE NEWSWIRE) -- Cano Health, Inc. (NYSE: CANO or the “Company”), a leading value-based primary care provider and population health company, will host a conference call on Tuesday, August 9, 2022, at 5:00 PM Eastern Time to review the Company's business and financial results for the second quarter ended June 30, 2022. A press release with the results will be issued prior to the call.

Cano Health to Announce Second Quarter 2022 Results

Miami, FL, July 18, 2022 (GLOBE NEWSWIRE) -- Cano Health is proud to host Healthcare World of Tomorrow, an interactive program at L'ATTITUDE 2022 in San Diego, California on September 22-25, 2022. This program will include Continuing Medical Education (CME) sessions, networking and business opportunities, and panel discussions with leaders in healthcare.  It is designed for primary care physicians, physician executives, advanced practice clinicians, medical students, and others involved in the delivery of primary care services.

Cano Health to Host Healthcare World of Tomorrow at L'ATTITUDE 2022

Cano Health, Inc. (CANO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Cano Health, Inc. (CANO) Stock Jumps 17.1%: Will It Continue to Soar?

MIAMI , June 7, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, is hosting its 2022 Investor Day today. Members of the management team will provide updates on the business, including greater visibility into its strategy, medical center and affiliate operations, and expectations for short- and long-term financial performance.

Cano Health Investor Day to Provide Update on Strategy, Operations and Outlook

MIAMI , June 2, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced additional details regarding its 2022 Investor Day and its participation in an upcoming investor conference: Cano Health 2022 Investor Day in New York, NY on Tuesday June 7, 2022, from 9:30 AM ET until 1:00 PM ET. Participants are encouraged to pre-register for the event using the following link.

Cano Health to Host Investor Day and Participate in Upcoming Investor Conference

Los Angeles, California--(Newsfile Corp. - May 17, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cano Health, Inc. f/k/a Jaws Acquisition Corp. ("Cano" or "the Company") (NYSE: CANO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 18, 2020 and...

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Cano Health, Inc. with Losses of $100,000 to Contact the Firm

Jaws Acquisition Corp

New York, New York--(Newsfile Corp. - May 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cano Health, Inc. f/k/a Jaws Acquisition Corp. (NYSE: CANO) (NYSE: CANO.WS) (NYSE: JWS) (NYSE: JWS.U) (NYSE: JWS WS) between May 18, 2020 and February 25, 2022, inclusive (the "Class Period"), of the important May 17, 2022 lead plaintiff deadline.SO WHAT: If you purchased Cano Health securities during the Class...

CANO TUESDAY DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CANO, CANO.WS, JWS, JWS.U, JWS WS

New York, New York--(Newsfile Corp. - May 16, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cano Health, Inc. ("Cano" or the "Company") f/k/a Jaws Acquisition Corp. ("Jaws") (NYSE: CANO) (NYSE: CANO.WS) (NYSE: JWS) (NYSE: JWS.U) (NYSE: JWS.WS) and certain of its officers on behalf of purchasers of Cano securities between May 18, 2020 and February 25, 2022, both dates inclusive (the "Class Period"). Such...

CANO; CANO.WS; JWS; JWS.U; JWS.WS Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Cano Health, Inc. Investors of Class Action and Last Few Hours to Actively Participate

New York, New York--(Newsfile Corp. - May 13, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cano Health, Inc. f/k/a Jaws Acquisition Corp. (NYSE: CANO) (NYSE: CANO.WS) (NYSE: JWS) (NYSE: JWS.U) (NYSE: JWS.WS) between May 18, 2020 and February 25, 2022, inclusive (the "Class Period"), of the important May 17, 2022 lead plaintiff deadline.SO WHAT: If you purchased Cano Health securities during the Class Period...

CANO FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors With Losses Over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CANO, CANO.WS, JWS, JWS.U, JWS WS

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May 17, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Cano Health, Inc. (“Cano” or the “Company”) f/k/a Jaws Acquisition Corp. (“Jaws”) (NYSE: CANO) securities between May 18, 2020 and February 25, 2022, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On June 3, 2021, Jaws, a specia

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cano Health, Inc. f/k/a Jaws Acquisition Corp. (CANO)

BENSALEM, Pa. , May 12, 2022 /PRNewswire/ -- Law Offices of Howard G.

CANO Investors Have Opportunity to Lead Cano Health, Inc. f/k/a Jaws Acquisition Corp. Securities Fraud Lawsuit

Cano Health, Inc. (NYSE:CANO ) Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Marlow Hernandez - Chairman and Chief Executive Officer Brian Koppy - Chief Financial Officer Conference Call Participants Adam Braun - Bank of America Jason Cassorla - Citi Brian Tanquilut - Jeffries Justin Lake - Wolfe Research Josh Raskin - Nephron Research Adam Ron - Bank of America Operator Good morning and welcome to Cano's Health First Quarter 2022 Earnings Call. Currently, all participants are in a listen-only mode.

Cano Health, Inc. (CANO) CEO Dr. Marlow Hernandez on Q1 2022 Results - Earnings Call Transcript

NEW YORK , May 9, 2022 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cano Health, Inc. f/k/a Jaws Acquisition Corp. (NYSE: CANO, CANO.WS, JWS, JWS.U, JWS WS) between May 18, 2020 and February 25, 2022, inclusive (the "Class Period"), of the important May 17, 2022 lead plaintiff deadline. SO WHAT: If you purchased Cano Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cano Health, Inc. f/k/a Jaws Acquisition Corp. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CANO, CANO.WS, JWS, JWS.U, JWS WS

Maintains Full Year Guidance MIAMI, May 9, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the first quarter ended March 31, 2022. First Quarter Financial Results Total membership of 269,333, including 160,306 Medicare capitated members, an increase of 130% and 112%, respectively year-over-year Total revenue of $704.3 million, an increase of 156% year-over-year Net loss of $0.1 million, benefiting from a $27.2 million fair value adjustment of warrant liabilities Adjusted EBITDA1 of $45.0 million, compared to $17.5 million in the first quarter of 2021, an increase of 157% year-over-year As of May 6, 2022, the Company had approximately 208 million shares of Class A common stock and 277 million shares of Class B common stock issued and outstanding.

News for Cano Health Stock (CANO)